Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,648   7.83  Index Moved Down -0.47%
FNMFO FNMFO 096770 KDDIF ISP Realty Junk Bonds Commodities 
United States GSPC USD ...  |  Investing Themes


Processing
Collecting data for NVSEF

Novartis quote and profile

 
 Companies |  Insiders  | Dashboard  
     
74.66
  
OTC STOCK
0.00  No Change   0.00%  
Year To Date
0.075.34
Last 1 Month(s)
72.4575.34
May 23 2013 

Diversification Suggestion

Use Novartis to protect against small markets fluctuations. The stock experiences no pattern. Wait for more market signals and watch out for any hype
Analyze Novartis AG Trend or Check current 30 days Novartis correlation with market (S&P 500)
1 Month Beta -0.25  
Highest Price:  
Lowest Price:  
75.34  
72.45  
May 16 2013 
April 23 2013 
As returns on market increase, returns on owning Novartis are expected to decrease at a much smaller rate. During bear market, Novartis is likely to outperform the market.
Novartis AG Almost negative betaNovartis AG Beta Legend
NVSEF United States OTC
Novartis AG
Benchmark S&P 500
http://www.novartis.com
Contact Number: 41 61 324 11 11
Traded on OTC Market
    
Current Valuation143.59 B
Shares Outstanding2.42 B
Revenue59.07 B
EBITDA17.05 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 thisGreen NVSEF NVSEF.PK agains markets  0.00 % No Change  
 United States Russel   0.38 % Macroaxis: 0.38 Moved Down  
 
 United States SP 500   0.39 % Macroaxis: 0.39 Moved Down  
 
 United States NYSE   0.79 % Macroaxis: 0.79 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Novartis Leadership

Joseph Jimenez CEO, Member of the Executive Committee, MBA
Daniel Vasella Chairman of the Board of Directors, Ph.D
Ulrich Lehner Vice Chairman of the Board of Directors, Non-Executive Director, MBA
Mark Fishman Member of the Executive Committee and President of Novartis Institute for BioMedical Research (NIBR), Ph.D

Novartis Price and Market Media

The median price of Novartis for the period between Tue, Apr 23, 2013 and Thu, May 23, 2013 is 73.9 with a coefficient of variation of 1.18. The daily time series for the period is distributed with a sample standard deviation of 0.87, arithmetic mean of 73.87, and mean deviation of 0.67. The Stock did not receive any noticable media coverage during the period.
Novartis         SP 500
Price Growth (%)
 

Novartis Summary

Novartis AG [NVSEF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Mega-Cap' category with current market capitalization of 124.39 B. Novartis AG has 2.42 B outstanding shares.
Novartis AG, through its subsidiaries, engages in the research, development, manufacture, and marketing of healthcare solutions worldwide. more
Past Market
Over 30
Days
10
Out Of
100
 
Chance of
Less
Than
29 %
 
Follow Novartis with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Novartis to your reader
 

Novartis Research Report

Novartis vs. Federal

Correlation analysis and fundamentals comparison between Novartis AG and Federal National Mor

Novartis Executives

Jonathan Symonds CFO, Member of the Executive Committee

Novartis Directors

Andreas Planta Member of the Board of Directors
Pierre Landolt Member of the Board of Directors
Srikant Datar Member of the Board of Directors, MBA
Ann Fudge Member of the Board of Directors
Rolf Zinkernagel Member of the Board of Directors

Novartis Management

Felix Ehrat Member of the Executive Committee, Group General Counsel, Ph.D
David Epstein Member of the Executive Committee, Division Head, Pharmaceuticals, MBA
Naomi Kelman Member of the Executive Committee, Division Head, Novartis OTC, MBA
Juergen Brokatzky-Geiger Head Human Resources and Member of the Executive Committee, Ph.D
Jeffrey George Member of the Executive Committee and Division Head, Sandoz, MBA

Novartis Fundamentals

Current Ratio vs Profit Margin
Z Score vs Total Debt
Current Ratio vs Price to Book
Number of Employees vs Total Debt

Novartis vs Competition

Novartis vs. Federal National Mortgage Association
Novartis vs. Federal National Mortgage Association
Novartis vs. SK Innovation
Novartis vs. KDDI Corp
Novartis vs. Japan Tobacco Inc
Novartis vs. Inpex Corporation
Novartis vs. AP M
Novartis vs. AP M
Novartis vs. Citigroup Inc
Novartis vs. Akbank TAS

Novartis May 23 2013 Opportunity Range

Downside Deviation1.43
Information Ratio(0.11)
Maximum Drawdown3.45
Value At Risk(0.54)
Potential Upside1.37

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium